Skip to content
October 18, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Popular Tags
  • Patient Advocacy and Support
  • Treatment Innovations
  • Genomics and Precision Medicine
  • Medical Research and Clinical Trials
  • Survivorship and Post-Treatment
  • Integrative Oncology and Holistic Care
  • Chemotherapy and Targeted Therapy
  • Global Breast Cancer Awareness
  • Breast Cancer Legislation and Policy
  • Breast Cancer Surgery and Reconstruction
Breaking News
breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1 MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research a-paradigm-shift-in-oncology-karen-and-rob-hale-commit-record-breaking-50-million-to-breast-cancer-research A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research

Main News

breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026
a-paradigm-shift-in-oncology-karen-and-rob-hale-commit-record-breaking-50-million-to-breast-cancer-research
  • Patient Advocacy and Support

A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research

Pevita Pearce October 18, 2026
  • Recommended
  • Popular
  • Archive
  • Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
    • Medical Research and Clinical Trials

    Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

    Asep Darmawan October 18, 2026
  • MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
    • Medical Research and Clinical Trials

    MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

    Sagoh October 18, 2026
  • Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
    • Patient Advocacy and Support

    Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

    Nana Muazin October 18, 2026
  • Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
    • Patient Advocacy and Support

    Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

    Ali Ikhwan October 18, 2026
  • Navigating the Complexity: The FDA’s Ambitious New Strategy for Rare Disease Drug Development navigating-the-complexity-the-fdas-ambitious-new-strategy-for-rare-disease-drug-development
    • Treatment Innovations

    Navigating the Complexity: The FDA’s Ambitious New Strategy for Rare Disease Drug Development

    Siti Muinah October 18, 2026
  • Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day® beyond-the-diagnosis-uniting-the-world-for-the-39th-national-cancer-survivors-day
    • Survivorship and Post-Treatment

    Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day®

    Lina Irawan May 8, 2026 0
  • Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients detalimogene-voraplasmid-shows-promising-efficacy-and-tolerability-in-bcg-unresponsive-nmibc-offering-new-hope-for-patients
    • Medical Research and Clinical Trials

    Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients

    Lina Irawan May 9, 2026 0
  • A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer a-paradigm-shift-in-oncology-nccn-guidelines-embrace-ai-to-predict-not-just-detect-breast-cancer
    • Patient Advocacy and Support

    A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer

    Lina Irawan May 9, 2026 0
  • Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
    • Medical Research and Clinical Trials

    Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

    Asep Darmawan October 18, 2026
  • MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
    • Medical Research and Clinical Trials

    MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

    Sagoh October 18, 2026
  • Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
    • Patient Advocacy and Support

    Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

    Nana Muazin October 18, 2026
  • Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
    • Patient Advocacy and Support

    Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

    Ali Ikhwan October 18, 2026

Featured News

breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026

General

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026

Opinion

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026

More

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026
Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...
Read More Read more about Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
A pioneering investigational therapy, MGC030, developed by US-based biopharmaceutical company MacroGenics, has reached a significant milestone with...
Read More Read more about MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors
Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
Introduction In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists, commonly known as GLP-1 medications, have revolutionized the...
Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research
Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026
NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
Read More Read more about Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research
A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research a-paradigm-shift-in-oncology-karen-and-rob-hale-commit-record-breaking-50-million-to-breast-cancer-research
  • Patient Advocacy and Support

A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research

Pevita Pearce October 18, 2026
NEW YORK, NY – In a move that signals a new era for oncological philanthropy and scientific...
Read More Read more about A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research
Webinar: Living Well After Breast Cancer webinar-living-well-after-breast-cancer
  • Patient Advocacy and Support

Webinar: Living Well After Breast Cancer

Ali Ikhwan October 18, 2026
By [Your Name/Agency] October 10, 2026 OTTAWA – For many breast cancer patients, the sound of the...
Read More Read more about Webinar: Living Well After Breast Cancer
Bridging the Global Data Gap: The WHO’s SCORE Initiative and the Future of Health Intelligence bridging-the-global-data-gap-the-whos-score-initiative-and-the-future-of-health-intelligence
  • Breast Cancer Prevention and Lifestyle

Bridging the Global Data Gap: The WHO’s SCORE Initiative and the Future of Health Intelligence

Iffa Jayyana October 18, 2026
Introduction: The Imperative of Data in a Post-Pandemic World In an era defined by global health crises,...
Read More Read more about Bridging the Global Data Gap: The WHO’s SCORE Initiative and the Future of Health Intelligence
Beyond the Hype: Can Iambic Therapeutics Succeed Where Other AI Drug Developers Have Faltered? beyond-the-hype-can-iambic-therapeutics-succeed-where-other-ai-drug-developers-have-faltered
  • Treatment Innovations

Beyond the Hype: Can Iambic Therapeutics Succeed Where Other AI Drug Developers Have Faltered?

Ali Ikhwan October 18, 2026
The intersection of artificial intelligence and pharmaceutical research has long been promised as the "holy grail" of...
Read More Read more about Beyond the Hype: Can Iambic Therapeutics Succeed Where Other AI Drug Developers Have Faltered?
Radiology’s Digital Transformation: Sirona Medical Secures $40M to Scale AI-Native "RadOS" Globally radiologys-digital-transformation-sirona-medical-secures-40m-to-scale-ai-native-rados-globally
  • Treatment Innovations

Radiology’s Digital Transformation: Sirona Medical Secures $40M to Scale AI-Native "RadOS" Globally

Raul Delapena Setiawan October 18, 2026
In a landmark development for the medical imaging sector, California-based Sirona Medical has successfully closed a $40...
Read More Read more about Radiology’s Digital Transformation: Sirona Medical Secures $40M to Scale AI-Native "RadOS" Globally
Navigating the Orphan Landscape: The FDA’s Ambitious New "Rare Disease Framework Initiative" navigating-the-orphan-landscape-the-fdas-ambitious-new-rare-disease-framework-initiative
  • Treatment Innovations

Navigating the Orphan Landscape: The FDA’s Ambitious New "Rare Disease Framework Initiative"

Nana Muazin October 18, 2026
In a significant move to modernize its oversight of the orphan drug sector, the U.S. Food and...
Read More Read more about Navigating the Orphan Landscape: The FDA’s Ambitious New "Rare Disease Framework Initiative"

Posts pagination

1 2 3 4 … 778 Next

Recent Posts

  • Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
  • MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors
  • Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research
  • Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research
  • A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

breakthrough-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026
macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-evolving-research
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Evolving Research

Nana Muazin October 18, 2026
global-landmarks-to-glow-teal-green-and-pink-a-massive-mobilization-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: A Massive Mobilization for Metastatic Breast Cancer Research

Ali Ikhwan October 18, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.